Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boeve

Showing results (761-770 of 957) with videos related to

Pageof 96
Sort By:
Neurology|September 29, 2020
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Scott A Przybelski, Timothy G Lesnick, et al.
Acta Neuropathologica Communications|October 23, 2020
Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsySamantha L Strickland, Hélène Morel, Christian Prusinski, et al.
JAMA Network Open|October 28, 2020
Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic VariantsAdam M Staffaroni, Sheng-Yang M Goh, Yann Cobigo, et al.
Acta Neuropathologica|June 6, 2025
Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicingJúlia Faura, Bavo Heeman, Cyril Pottier, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 21, 2024
Clinicoradiological and neuropathological evaluation of primary progressive aphasiaDror Shir, Nick Corriveau-Lecavalier, Camilo Bermudez Noguera, et al.
Molecular Neurodegeneration|April 27, 2016
Network-driven plasma proteomics expose molecular changes in the Alzheimer's brainPhilipp A Jaeger, Kurt M Lucin, Markus Britschgi, et al.
Neurology|January 5, 2024
Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy ConsortiumParichita Choudhury, Joyce K Lee-Iannotti, Andrea O Busicescu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2016
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodiesCatherine Labbé, Michael G Heckman, Oswaldo Lorenzo-Betancor, et al.
Neurobiology of Aging|July 28, 2016
RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodiesKyndall Hodges, Sheridan S Brewer, Catherine Labbé, et al.
JAMA Neurology|April 3, 2023
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal SyndromeLawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, et al.
Pageof 96

Showing results (761-770 of 957) with videos related to

Sort By:
Pageof 96
Neurology|September 29, 2020
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Scott A Przybelski, Timothy G Lesnick, et al.
Acta Neuropathologica Communications|October 23, 2020
Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsySamantha L Strickland, Hélène Morel, Christian Prusinski, et al.
JAMA Network Open|October 28, 2020
Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic VariantsAdam M Staffaroni, Sheng-Yang M Goh, Yann Cobigo, et al.
Acta Neuropathologica|June 6, 2025
Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicingJúlia Faura, Bavo Heeman, Cyril Pottier, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 21, 2024
Clinicoradiological and neuropathological evaluation of primary progressive aphasiaDror Shir, Nick Corriveau-Lecavalier, Camilo Bermudez Noguera, et al.
Molecular Neurodegeneration|April 27, 2016
Network-driven plasma proteomics expose molecular changes in the Alzheimer's brainPhilipp A Jaeger, Kurt M Lucin, Markus Britschgi, et al.
Neurology|January 5, 2024
Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy ConsortiumParichita Choudhury, Joyce K Lee-Iannotti, Andrea O Busicescu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2016
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodiesCatherine Labbé, Michael G Heckman, Oswaldo Lorenzo-Betancor, et al.
Neurobiology of Aging|July 28, 2016
RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodiesKyndall Hodges, Sheridan S Brewer, Catherine Labbé, et al.
JAMA Neurology|April 3, 2023
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal SyndromeLawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, et al.
Pageof 96